MeSH tree: D23.050.865.450
German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in Britain using the same mRNA technology, the company said on Friday.
Jan 6, 2023
0
138
Researchers at the AIDS Institute, Department of Microbiology, School of Clinical Medicine, and the State Key Laboratory of Emerging Infectious Diseases, LKS Faculty of Medicine of The University of Hong Kong (HKUMed) reveals ...
Jan 4, 2023
0
137
The first reports that several women experienced menstrual disturbances after coronavirus vaccination came early in summer 2021. The Norwegian Institute of Public Health (NIPH) promptly introduced questions about menstrual ...
Dec 19, 2022
0
124
Less known to the general public, mucosal vaccination via the mucus membranes could provide robust protection against SARS-CoV-2 infections. Immune cells in the nose and lungs are considered better prepared to encounter and ...
Dec 16, 2022
0
54
Adult hospitalizations from omicron-related SARS-CoV-2 (COVID-19) were less severe than delta and the Pfizer-BioNTech vaccine (also known as Comirnaty and BNT162b2) remains effective in preventing not only hospitalization, ...
Dec 13, 2022
0
73
Moderna's stock soared Tuesday after the COVID-19 vaccine maker detailed progress in developing a preventive shot for a deadly form of skin cancer.
Dec 13, 2022
0
42
People infected with HIV who receive antiretroviral therapy form antibodies against SARS-CoV-2 after being vaccinated against COVID with mRNA vaccines. Their immune response to the vaccination is, however, less strong than ...
Dec 9, 2022
0
74
In 2021, a group of scientists led by researchers at the University of North Carolina at Chapel Hill, Weill Cornell Medicine and NewYork-Presbyterian reported that the Moderna mRNA vaccine and a protein-based vaccine candidate ...
Dec 1, 2022
0
100
The effectiveness of COVID-19 vaccines in preventing death remains high in children and adolescents regardless of the predominant circulating variant, suggests a large study from Argentina published by The BMJ today.
Nov 30, 2022
2
76
A large study found that myocarditis after SARS-CoV-2 vaccination was rare but higher in younger males, especially after the second mRNA-1273 (Moderna) vaccine, suggesting that vaccine type, age and sex should be considered ...
Nov 21, 2022
0
254
